Document Classification

Section Type: RESULTS

Text: ALT level decreased from 68. 2 U/L + / -68. 6 U/L to 45. 9 U/L + / -26. 1 U/L, AST level decreased from 60. 4 U/L + / -62. 6 U/L to 46. 7 U/L + / -39. 0 U/L (P < 0. 05) after 24 weeks treatment, whereas there was no significant change in placebo group (ALT : 65. 3 U/L + / -48. 3 U/L to 85. 4 U/L + / -115. 5 U/L ; AST : 60. 4 U/L + / -44. 6 U/L to 77. 6 U/L + / -89. 6 U/L, P > 0. 05).